Anthropic has launched Claude for Life Sciences, a specialized AI suite engineered to automate the complete scientific research lifecycle, from initial hypothesis generation through final regulatory submission.
The platform utilizes task-specific Agent Skills. In early testing, the system surpassed human performance in genomic quality control. On a standard protocol QA benchmark for single-cell RNA-seq, the Claude Sonnet 4.5 model scored 0.83, exceeding the recorded human expert baseline of 0.79.
To integrate directly into existing lab infrastructure, Anthropic introduced connectors for critical scientific platforms. This allows researchers to manipulate molecular biology data in Benchling, generate imagery in BioRender, and search peer-reviewed literature on PubMed without disrupting their existing workflow.
Anthropic is incentivizing academic adoption through a new AI for Science program offering free API credits to nonprofit, high-impact researchers. The venture is launching with high-profile institutional backing from pharmaceutical giant Sanofi and the MIT and Harvard-affiliated Broad Institute.